-
1
-
-
0032581450
-
An evaluation of phase I cancer clinical trial designs
-
Ahn, C. (1998) An evaluation of phase I cancer clinical trial designs. Stat. in Med., 17, 1537-19.
-
(1998)
Stat. in Med
, vol.17
, pp. 1537-1519
-
-
Ahn, C.1
-
2
-
-
2642664485
-
The application of stochastic methods to the bioassay problem
-
Anbar, D. (1977) The application of stochastic methods to the bioassay problem. J. Statist. Planning Inference, 1, 191-206.
-
(1977)
J. Statist. Planning Inference
, vol.1
, pp. 191-206
-
-
Anbar, D.1
-
3
-
-
0011665245
-
A stochastic Newton-Raphson method
-
Anbar, D. (1978) A stochastic Newton-Raphson method. J. Statist. Planning Inference, 2, 153-63.
-
(1978)
J. Statist. Planning Inference
, vol.2
, pp. 153-163
-
-
Anbar, D.1
-
4
-
-
0005499775
-
Stochastic approximation methods and their use in bioassay and phase I clinical trials
-
Anbar, D. (1984) Stochastic approximation methods and their use in bioassay and phase I clinical trials. Commun. Statist., 13, 2451-2467.
-
(1984)
Commun. Statist
, vol.13
, pp. 2451-2467
-
-
Anbar, D.1
-
5
-
-
0031920799
-
Cancer phase I clinical trials: Efficient dose escalation with overdose control
-
Babb J., Rogatko A., and Zacks S. (1998) Cancer phase I clinical trials: efficient dose escalation with overdose control. Stat. in Med., 17, 1103-20.
-
(1998)
Stat. in Med
, vol.17
, pp. 1103-1120
-
-
Babb, J.1
Rogatko, A.2
Zacks, S.3
-
6
-
-
0027319907
-
The continual reassessment method in cancer phase I clinical trials: A simulation study
-
Chevret, S. (1993) The continual reassessment method in cancer phase I clinical trials: a simulation study. Stat. in Med., 12, 1093-1108.
-
(1993)
Stat. in Med
, vol.12
, pp. 1093-1108
-
-
Chevret, S.1
-
7
-
-
0028060511
-
Practical modifications of the continual reassessment method for phase I cancer clinical trials
-
Faries, D. (1994) Practical modifications of the continual reassessment method for phase I cancer clinical trials. J. Biopharm. Statist., 4, 147-64.
-
(1994)
J. Biopharm. Statist
, vol.4
, pp. 147-164
-
-
Faries, D.1
-
8
-
-
0026663871
-
Bayesian methods for phase I clnical trials
-
Gatsonis, C. and Greenhouse, J.B. (1992) Bayesian methods for phase I clnical trials. Stat. in Med., 11, 1377-1389.
-
(1992)
Stat. in Med
, vol.11
, pp. 1377-1389
-
-
Gatsonis, C.1
Greenhouse, J.B.2
-
9
-
-
0029027770
-
Some practical improvements in the continual reassessment method for phase I studies
-
Goodman, S., Zahurak, M.L., and Piantadosi, S. (1995) Some practical improvements in the continual reassessment method for phase I studies. Stat. in Med., 14, 1149-61.
-
(1995)
Stat. in Med
, vol.14
, pp. 1149-1161
-
-
Goodman, S.1
Zahurak, M.L.2
Piantadosi, S.3
-
10
-
-
0027949027
-
Simulation as a design tool for phase I/II clinical trials. An example from bone marrow transplantation
-
Gooley, T.A., Martin, P.J., Fisher, L.D., and Pettinger, M. (1994) Simulation as a design tool for phase I/II clinical trials. An example from bone marrow transplantation. Controlled Clin. Trials. 15, 450-62.
-
(1994)
Controlled Clin. Trials
, vol.15
, pp. 450-462
-
-
Gooley, T.A.1
Martin, P.J.2
Fisher, L.D.3
Pettinger, M.4
-
11
-
-
0000250624
-
The behavior of maximum likelihood estimates under nonstandard conditions
-
Huber, P.J. (1967) The behavior of maximum likelihood estimates under nonstandard conditions. Proc. 6th Berkeley Symp., 1, 221-233.
-
(1967)
Proc. 6th Berkeley Symp
, vol.1
, pp. 221-233
-
-
Huber, P.J.1
-
12
-
-
85123815374
-
A new dose-finding design for bivariate outcomes
-
Ivanova, A. (2003) A new dose-finding design for bivariate outcomes. Biometrics 57, 1018-29.
-
(2003)
Biometrics
, vol.57
, pp. 1018-1029
-
-
Ivanova, A.1
-
13
-
-
0028170238
-
A comparison of two phase I trial designs
-
Korn, E.L., Midthune, D., Chen, T.T., Rubinstein, L.V., Christian, M.C., and Simon, R. (1994) A comparison of two phase I trial designs. Stat. in Med., 13, 1799-1806.
-
(1994)
Stat. in Med
, vol.13
, pp. 1799-1806
-
-
Korn, E.L.1
Midthune, D.2
Chen, T.T.3
Rubinstein, L.V.4
Christian, M.C.5
Simon, R.6
-
14
-
-
0027499297
-
Model-guided determination of maximum tolerated dose in phase I clinical trials: Evidence for increased precision
-
Mick, R. and Ratain, M.J. (1993) Model-guided determination of maximum tolerated dose in phase I clinical trials: evidence for increased precision. J.Natl. Cancer Inst., 85, 217-223.
-
(1993)
J.Natl. Cancer Inst
, vol.85
, pp. 217-223
-
-
Mick, R.1
Ratain, M.J.2
-
15
-
-
0029001313
-
An extension of the continual reassessment method using a preliminary up and down design in a dose finding study in cancer patients in order to investigate a greater number of dose levels
-
Moller, S. (1995) An extension of the continual reassessment method using a preliminary up and down design in a dose finding study in cancer patients in order to investigate a greater number of dose levels. Stat. in Med., 14, 911-22.
-
(1995)
Stat. in Med
, vol.14
, pp. 911-922
-
-
Moller, S.1
-
16
-
-
0037614842
-
Interval estimates of the probability of toxicity at the maximum tolerated dose for small samples
-
Natarajan, L. and O'Quigley J. (2003) Interval estimates of the probability of toxicity at the maximum tolerated dose for small samples. Stat. in Med., 22, 1829-36.
-
(2003)
Stat. in Med
, vol.22
, pp. 1829-1836
-
-
Natarajan, L.1
O'Quigley, J.2
-
17
-
-
0026725698
-
Estimating the probability of toxicity at the recommended dose following a phase I clinical trial in cancer
-
O'Quigley, J. (1992) Estimating the probability of toxicity at the recommended dose following a phase I clinical trial in cancer. Biometrics, 48, 853-862.
-
(1992)
Biometrics
, vol.48
, pp. 853-862
-
-
O'Quigley, J.1
-
18
-
-
0025148278
-
Continual reassessment method: A practical design for phase I clinical trials in cancer
-
O'Quigley, J., Pepe, M., Fisher, L. (1990) Continual reassessment method: a practical design for phase I clinical trials in cancer. Biometrics, 46, 33-48.
-
(1990)
Biometrics
, vol.46
, pp. 33-48
-
-
O'Quigley, J.1
Pepe, M.2
Fisher, L.3
-
19
-
-
0025986460
-
Methods for dose finding studies in cancer clinical trials: A review and results of a Monte Carlo study
-
O'Quigley, J. and Chevret, S. (1991) Methods for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study. Stat. in Med., 10, 1647-1664.
-
(1991)
Stat. in Med
, vol.10
, pp. 1647-1664
-
-
O'Quigley, J.1
Chevret, S.2
-
20
-
-
0029938415
-
Continual reassessment method: A likelihood approach
-
O'Quigley, J. and Shen L.Z. (1996) Continual reassessment method: a likelihood approach. Biometrics, 52, 163-174.
-
(1996)
Biometrics
, vol.52
, pp. 163-174
-
-
O'Quigley, J.1
Shen, L.Z.2
-
21
-
-
0000589197
-
A stopping rule for the continual reassessment method
-
O'Quigley, J. and Reiner E., (1998) A stopping rule for the continual reassessment method. Biometrika, 85, 741-18.
-
(1998)
Biometrika
, vol.85
, pp. 741-718
-
-
O'Quigley, J.1
Reiner, E.2
-
22
-
-
0033619523
-
Another look at two phase I clinical trial designs (with commentary)
-
O'Quigley, J. (1999) Another look at two phase I clinical trial designs (with commentary). Stat. in Med., 18, 2683-92.
-
(1999)
Stat. in Med
, vol.18
, pp. 2683-2692
-
-
O'Quigley, J.1
-
23
-
-
0032978158
-
Two sample continual reassessment method
-
O'Quigley, J., Shen, L., and Gamst, A. (1999) Two sample continual reassessment method. J. Biopharm. Statist., 9, 17-44.
-
(1999)
J. Biopharm. Statist
, vol.9
, pp. 17-44
-
-
O'Quigley, J.1
Shen, L.2
Gamst, A.3
-
24
-
-
0035186085
-
Dose finding designs for HIV studies
-
O'Quigley, J., Hughes, M., and Fenton, T. (2001) Dose finding designs for HIV studies. Biometrics 57, 1018-29.
-
(2001)
Biometrics
, vol.57
, pp. 1018-1029
-
-
O'Quigley, J.1
Hughes, M.2
Fenton, T.3
-
25
-
-
1142304984
-
Non-parametric optimal design in dose finding studies
-
O'Quigley J., Paoletti, X., and Maccario, J. (2002) Non-parametric optimal design in dose finding studies. Biostatics 3, 51-56.
-
(2002)
Biostatics
, vol.3
, pp. 51-56
-
-
O'Quigley, J.1
Paoletti, X.2
Maccario, J.3
-
27
-
-
0029780751
-
Improved designs for dose escalation studies using pharmacokinetic measurements
-
Piantadosi, S. and Liu, G. (1996) Improved designs for dose escalation studies using pharmacokinetic measurements. Stat. in Med., 15, 1605-18.
-
(1996)
Stat. in Med
, vol.15
, pp. 1605-1618
-
-
Piantadosi, S.1
Liu, G.2
-
28
-
-
0032648126
-
Operating characteristics of the standard phase I clinical trial design
-
Reiner E., Paoletti, X., and O'Quigley (1998) Operating characteristics of the standard phase I clinical trial design. Comp. Statist. and Data Anal., 30, 303-315.
-
(1998)
Comp. Statist. and Data Anal
, vol.30
, pp. 303-315
-
-
Reiner, E.1
Paoletti, X.2
O'Quigley3
-
29
-
-
0000016172
-
A stochastic approximation method
-
Robbins, H. and Monro, S. (1951) A stochastic approximation method. Annals of Math. Stat., 29, 351-56.
-
(1951)
Annals of Math. Stat
, vol.29
, pp. 351-356
-
-
Robbins, H.1
Monro, S.2
-
30
-
-
33746402001
-
Consistency of continual reassessment method in dose finding studies
-
Shen, L.Z. and O'Quigley, J. (1996) Consistency of continual reassessment method in dose finding studies. Biometrika, 83, 395-406.
-
(1996)
Biometrika
, vol.83
, pp. 395-406
-
-
Shen, L.Z.1
O'Quigley, J.2
-
31
-
-
0030749549
-
Accelerated titration designs for phase I clinical trials in oncology
-
Simon, R., Freidlin, B., Rubinstein, L., Arbuck, S., Collins, J., and Christian, M. (1997) Accelerated titration designs for phase I clinical trials in oncology. J. Natl. Cancer Inst., 89, 1138-1147.
-
(1997)
J. Natl. Cancer Inst
, vol.89
, pp. 1138-1147
-
-
Simon, R.1
Freidlin, B.2
Rubinstein, L.3
Arbuck, S.4
Collins, J.5
Christian, M.6
-
32
-
-
0000950512
-
On the existence of maximum likelihood estimators for the binomial response models
-
Silvapulle, M.J. (1981) On the existence of maximum likelihood estimators for the binomial response models. J.R. Stat. Soc. B, 43, 310-313.
-
(1981)
J.R. Stat. Soc. B
, vol.43
, pp. 310-313
-
-
Silvapulle, M.J.1
-
33
-
-
0024452804
-
Design and analysis of phase I clinical trials
-
Storer, B.E. (1989) Design and analysis of phase I clinical trials. Biometrics, 45, 925-937.
-
(1989)
Biometrics
, vol.45
, pp. 925-937
-
-
Storer, B.E.1
-
34
-
-
0027745947
-
Small-sample confidence sets for the MTD in a phase I clinical trial
-
Storer, B.E. (1993) Small-sample confidence sets for the MTD in a phase I clinical trial. Biometrics, 49, 1117-25.
-
(1993)
Biometrics
, vol.49
, pp. 1117-1125
-
-
Storer, B.E.1
-
36
-
-
0031670630
-
Bayesian decision procedures based on logistic regression models for dose-finding studies
-
Whitehead, J. and Williamson, D. (1998) Bayesian decision procedures based on logistic regression models for dose-finding studies. J. Biopharm. Stat., 8, 445-67.
-
(1998)
J. Biopharm. Stat
, vol.8
, pp. 445-467
-
-
Whitehead, J.1
Williamson, D.2
-
37
-
-
84950861150
-
Efficient sequential designs with binary data
-
Wu, C.F.J. (1985) Efficient sequential designs with binary data, J. Amer. Stat. Assoc., 80, 974-984.
-
(1985)
J. Amer. Stat. Assoc
, vol.80
, pp. 974-984
-
-
Wu, C.F.J.1
-
38
-
-
0000144634
-
Maximum likelihood recursion and stochastic approximation in sequential designs
-
ed. J. van Ryzin, Institute of Mathematical Statistics Monograph 8, Hayward, CA: Institute of Mathematical Statistics
-
Wu, C.F.J. (1986) Maximum likelihood recursion and stochastic approximation in sequential designs, in Adaptive Statistical Procedures and Related Topics, ed. J. van Ryzin, Institute of Mathematical Statistics Monograph 8, Hayward, CA: Institute of Mathematical Statistics, 298-313.
-
(1986)
Adaptive Statistical Procedures and Related Topics
, pp. 298-313
-
-
Wu, C.F.J.1
|